Pharmacodynamic evaluation of mitomycin C analog BMS-181174 for potential use in intravesical bladder cancer therapy.

Pharmacodynamic evaluation of mitomycin C analog BMS-181174 for potential use in intravesical bladder cancer therapy. Pharm Res. 1997 Feb; 14(2):241-5.

View in: PubMed

subject areas

Administration, Intravesical
Administration, Intravesical
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Alkylating
Carcinoma, Squamous Cell
Carcinoma, Squamous Cell
Carcinoma, Transitional Cell
Carcinoma, Transitional Cell
Cell Survival
Cell Survival
Mitomycin
Mitomycin
Mitomycins
Mitomycins
Tumor Cells, Cultured
Tumor Cells, Cultured
Urinary Bladder Neoplasms
Urinary Bladder Neoplasms